• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

Researchers tout AI-based diabetes onset prediction method

December 2, 2022 By Sean Whooley

Klick Applied Sciences diabetes research

Scientists at Klick Applied Sciences say they discovered a way to use a continuous glucose monitor (CGM) as a diabetes screening tool. The scientists determined that they can use artificial intelligence (AI) to screen and prevent the chronic health condition. They used machine learning and 12 hours of data from CGMs to determine whether a […]

Filed Under: Diabetes, Diagnostics, Drug-Device Combinations, Featured, Patient Monitoring, Research & Development, Technology Tagged With: Klick Applied Sciences

BD opens $38.6M medication management manufacturing plant in Mexico

December 2, 2022 By Sean Whooley

This is the logo of BD.

BD (NYSE:BDX) announced recently that it inaugurated a new $38.6 million manufacturing facility in Tijuana, Mexico. Government officials from Mexico and the state of Baja California joined in the opening of the medication management plant. BD plans for the facility to produce devices and technologies that improve medication safety within healthcare settings. According to a […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: BD

BD warns on cybersecurity risk with BodyGuard infusion pumps

December 1, 2022 By Sean Whooley

BD BodyGuard infusion pump

The U.S. Cybersecurity and Infrastructure Security Agency (CISA) today issued an advisory regarding infusion pumps from BD (NYSE:BD). CISA’s advisory concerns the BD BodyGuard infusion pumps. They may contain a vulnerability in the form of a missing protection mechanism for an alternate hardware interface. No known public exploits specifically target this vulnerability, CISA said. Attackers […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Regulatory/Compliance Tagged With: BD, Cybersecurity

Dexcom G6 CGMs win reimbursement coverage in Japan

December 1, 2022 By Sean Whooley

Dexcom G6

Terumo announced today that the Japanese medical insurance system expanded reimbursement coverage for the Dexcom G6 CGM. Japan’s medical insurance system introduced a new category titled “C150.” It makes a wider range of people with diabetes eligible to receive reimbursement for the Dexcom G6 continuous glucose monitor (CGM) in Japan. Dexcom develops and manufactures the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology

Data supports digital diabetes program from Carbon Health

November 30, 2022 By Sean Whooley

Carbon Health digital diabetes program

Carbon Health today announced patient data from its digital diabetes program, highlighting improved outcomes. San Francisco-based Carbon Health designed its endocrinologist-led platform to integrate with primary care. A certified team of diabetes educators supports the completely virtual platform. It offers accessibility to patients with no waiting or travel time involved. Carbon Health’s electronic health record […]

Filed Under: Big Data, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Carbon Health

PharmaJet wins NIH grant to evaluate needle-free delivery of HPV immunization

November 29, 2022 By Sean Whooley

PharmaJet Tropis needle-free intradermal injection system

PharmaJet announced today that it received a grant worth $800,000-plus from the NIH to evaluate its needle-free injection system. Golden, Colorado-based PharmaJet picked up a Phase II grant from the NIH (National Institutes of Health). It allows the company to evaluate the immunogenicity of the intradermal administration of human papillomavirus virus (HPV) vaccine. The study […]

Filed Under: Business/Financial News, Clinical Trials, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Preclinical Trials Tagged With: National Institutes of Health, PharmaJet

GE HealthCare, Ulrich ink deal to offer multi-dose contrast media injector in U.S.

November 28, 2022 By Sean Whooley

GE Healthcare branded CT Motion injector

GE HealthCare today announced an agreement with Ulrich Medical to offer a GE HealthCare branded contrast media injector in the U.S. The CT motion multi-dose syringeless injector delivers iodinated contrast media for computed tomography (CT) imaging procedures. It helps to reduce procedure setup time and increase patient throughput by eliminating time-consuming preparation steps. Additionally, it […]

Filed Under: Business/Financial News, Drug-Device Combinations, Imaging Tagged With: GE Healthcare, Ulrich Medical

Ypsomed, CamDiab launch first automated insulin dosing system with Abbott FreeStyle Libre 3

November 28, 2022 By Sean Whooley

mylife loop camdiab ypsomed abbott freestyle libre 3

Ypsomed announced that its mylife Loop now has authorization to work with the Abbott FreeStyle Libre 3 sensor in Germany. The Ypsomed mylife YpsoPump combines with the CamDiab mylife CamAPS FX algorithm and FreeStyle Libre 3. Together, they form an intelligent and automated insulin delivery (AID) system for people with type 1 diabetes. Users can […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, CamDiab, Ypsomed

Bionaut Labs closes $43M Series B for robotic drug delivery tech

November 28, 2022 By Sean Whooley

Bionaut Labs robotic drug delivery

Robotic drug delivery technology developer Bionaut Labs announced today that it closed a Series B financing round worth $43.2 million. Los Angeles-based Bionaut Labs uses microscale robots to deliver drugs for treating central nervous system (CNS) diseases and disorders. Through magnetic propulsion, the company’s Bionauts can navigate the human body and deliver drugs locally. The […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Neurological, Oncology, Pharmaceuticals, Technology Tagged With: Bionaut Labs

How Sernova seeks to treat insulin-dependent diabetes with its Cell Pouch System

November 21, 2022 By Sean Whooley

Sernova Cell Pouch System Type 1 Diabetes

When Dr. Philip Toleikis joined Sernova in 2009, the company’s technology appeared as more of a concept than anything else. But, he saw the potential for something groundbreaking: A cure for type 1 diabetes (T1D). “I just thought it was an incredible idea,” said Toleikis, who serves as Sernova’s president and CEO. “We spent a […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Implants Tagged With: Sernova Inc

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 76
  • Page 77
  • Page 78
  • Page 79
  • Page 80
  • Interim pages omitted …
  • Page 168
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS